340b drug pricing program. Issues related to pharmacy benefit manager reform. Health care workforce. Health care supply chain. Health care drug shortages.
2025 · 4th Quarter (Oct 1 - Dec 31)
VIZIENT INC
Filed by MEHLMAN CONSULTING, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- MEHLMAN CONSULTING, INC.
- Client
- VIZIENT INC
- Filing UUID
- 09f0ca4c-1ffc-4f9a-95f2-17482088af7b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.